Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV positive and on ART~* 18-65 years of age~* Elevated substance use risk (ASSIST score greater than or equal to 4 for drugs or greater than or equal to 11 for alcohol)~* Have at least one of the following:~  1. Not attained viral suppression from first line ART (VL\>400 copies/mL)~ 2. On second-line ART treatment~ 3. Reinitiated first-line treatment within the past three months~ 4. Had a pharmacy non-refill at least once in the past 3 months~Exclusion Criteria:~* Inability to provide informed consent or complete procedures in English or isiXhosa~* Severe risk/likely dependence for opiates (ASSIST score \>26) because opiate substitution therapy may not be available~* Severe alcohol dependence symptoms that may warrant medical management of potential withdrawal symptoms~* Active, untreated, major mental illness (with untreated psychosis or mania) that would interfere with the paraprofessional adapted intervention

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Project Khanya (Type: EXPERIMENTAL): Those assigned to Project Khanya (the behavioral intervention for substance use and adherence condition) will have approximately 6 sessions (including Life-Steps, behavioral activation, and relapse prevention) delivered by a peer interventionist plus standard of care, which is typically referral to a local outpatient substance use treatment clinic. They will also receive a Wisepill, a wireless, real-time adherence monitoring device.
- ESOC (Type: NO_INTERVENTION): Those assigned to the ESOC (enhanced standard of care) condition will receive the standard of care, which is referral to a local substance use treatment clinic. The substance use clinics in the location that this study occurs follow the Matrix, and evidence-based 16-week outpatient program to treat substance use. We will enhance patients' normal referral to Matrix for ESOC participants by promoting facilitating and following up on the referral. Additionally, those in the control group will also receive a Wisepill, a wireless adherence monitoring device.

Based on this trial design, predict the completion outcome and termination type (if applicable).